Ivacaftor, a CFTR potentiator, synergizes with osimertinib against acquired resistance to osimertinib in NSCLC by regulating CFTR-PTEN-AKT axis
用户GnvoqL3Xl_SM
5天前
24
10
已完结
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2026-01-07 15:19:47 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

